Literature DB >> 28653891

Histone deacetylase 5 promotes the migration and invasion of hepatocellular carcinoma via increasing the transcription of hypoxia-inducible factor-1α under hypoxia condition.

Ming Ye1, Zejun Fang2, Hongqian Gu1, Rui Song3, Jiangwei Ye1, Hongzhang Li4, Zhiguang Wu1, Shenghui Zhou1, Peng Li1, Xiang Cai1, Xiaokun Ding1, Songshan Yu2.   

Abstract

Hypoxia plays a critical role in the progression and metastasis of hepatocellular carcinoma by activating the key transcription factor, hypoxia-inducible factor-1. This study aims to identify the novel mechanisms underlying the dysregulation of hypoxia-inducible factor-1α in hepatocellular carcinoma. We found that histone deacetylase 5, a highly expressed histone deacetylase in hepatocellular carcinoma, strengthened the migration and invasion of hepatocellular carcinoma cells under hypoxia but not normoxia condition. Furthermore, histone deacetylase 5 induced the transcription of hypoxia-inducible factor-1α by silencing homeodomain-interacting protein kinase-2 expression, which was also dependent on hypoxia. And then knockdown of hypoxia-inducible factor-1α decreased the expressions of mesenchymal markers, N-cadherin, and Vimentin, as well as matrix metalloproteinases, MMP7 and MMP9; however, the epithelial marker, E-cadherin, increased. Phenotype experiments showed that the migration and invasion of hepatocellular carcinoma cells were impaired by knockdown of histone deacetylase 5 or hypoxia-inducible factor-1α but rescued when eliminating homeodomain-interacting protein kinase-2 in hepatocellular carcinoma cells, which suggested the critical role of histone deacetylase 5-homeodomain-interacting protein kinase-2-hypoxia-inducible factor-1α pathway in hypoxia-induced metastasis. Finally, clinical analysis confirmed the positive correlation between histone deacetylase 5 and hypoxia-inducible factor-1α in hepatocellular carcinoma specimens and a relatively poor prognosis for the patients with high levels of histone deacetylase 5 and hypoxia-inducible factor-1α. Taken together, our findings demonstrated a novel mechanism underlying the crosstalk between histone deacetylase 5 and hypoxia-inducible factor-1 in hepatocellular carcinoma.

Entities:  

Keywords:  Hypoxia; hepatocellular carcinoma; histone deacetylase; homeodomain-interacting protein kinase-2; hypoxia-inducible factor-1

Mesh:

Substances:

Year:  2017        PMID: 28653891     DOI: 10.1177/1010428317705034

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  10 in total

Review 1.  Targeting Histone Deacetylases in Idiopathic Pulmonary Fibrosis: A Future Therapeutic Option.

Authors:  Martina Korfei; Poornima Mahavadi; Andreas Guenther
Journal:  Cells       Date:  2022-05-12       Impact factor: 7.666

Review 2.  Hypoxia-inducible factor-1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma.

Authors:  Huan Chen; Jing Chen; Huixin Yuan; Xiuhui Li; Weihua Li
Journal:  Oncol Lett       Date:  2022-06-28       Impact factor: 3.111

3.  Highly expressed histone deacetylase 5 promotes the growth of hepatocellular carcinoma cells by inhibiting the TAp63-maspin pathway.

Authors:  Hongqian Gu; Zejun Fang; Xiang Cai; Rui Song; Min Lin; Jiangwei Ye; Xiaokun Ding; Qinjian Ke; Haihong Chen; Chaoju Gong; Ming Ye
Journal:  Am J Cancer Res       Date:  2018-03-01       Impact factor: 6.166

4.  LncRNA-CCDC144NL-AS1 Promotes the Development of Hepatocellular Carcinoma by Inducing WDR5 Expression via Sponging miR-940.

Authors:  Yingying Zhang; Hongyu Zhang; Shuhuan Wu
Journal:  J Hepatocell Carcinoma       Date:  2021-05-03

5.  Prognosis Analysis of Histone Deacetylases mRNA Expression in Ovarian Cancer Patients.

Authors:  Lulu Zhou; Xiaohui Xu; Hailing Liu; Xiaoli Hu; Wenwen Zhang; Miaomiao Ye; Xueqiong Zhu
Journal:  J Cancer       Date:  2018-11-11       Impact factor: 4.207

6.  Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells.

Authors:  Julia Wanek; Martin Gaisberger; Marlena Beyreis; Christian Mayr; Katharina Helm; Florian Primavesi; Tarkan Jäger; Pietro Di Fazio; Martin Jakab; Andrej Wagner; Daniel Neureiter; Tobias Kiesslich
Journal:  Int J Mol Sci       Date:  2018-10-12       Impact factor: 5.923

7.  Alternative splicing variant of NRP/B promotes tumorigenesis of gastric cancer.

Authors:  Aram Kim; Bo Ram Mok; Soojung Hahn; Jongman Yoo; Dong Hyun Kim; Tae-Aug Kim
Journal:  BMB Rep       Date:  2022-07       Impact factor: 5.041

Review 8.  Insights Into the Function and Clinical Application of HDAC5 in Cancer Management.

Authors:  Jun Yang; Chaoju Gong; Qinjian Ke; Zejun Fang; Xiaowen Chen; Ming Ye; Xi Xu
Journal:  Front Oncol       Date:  2021-06-10       Impact factor: 6.244

9.  Hypoxia promotes the migration and invasion of human hepatocarcinoma cells through the HIF-1α-IL-8-Akt axis.

Authors:  Maoyun Fei; Jianming Guan; Tao Xue; Lianjin Qin; Chengwu Tang; Ge Cui; Yao Wang; Hui Gong; Wenming Feng
Journal:  Cell Mol Biol Lett       Date:  2018-09-20       Impact factor: 5.787

10.  Analysis of Transcription Factor-Related Regulatory Networks Based on Bioinformatics Analysis and Validation in Hepatocellular Carcinoma.

Authors:  Shui Liu; Xiaoxiao Yao; Dan Zhang; Jiyao Sheng; Xin Wen; Qingyu Wang; Gaoyang Chen; Zhaoyan Li; Zhenwu Du; Xuewen Zhang
Journal:  Biomed Res Int       Date:  2018-08-29       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.